SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-043142
Filing Date
2020-12-17
Accepted
2020-12-16 21:18:29
Documents
69
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_inmedpharma.htm 10-Q 835571
2 AMENDED AND RESTATED ARTICLES f10q0920ex3-1_inmed.htm EX-3.1 366250
3 CERTIFICATION f10q0920ex31-1_inmed.htm EX-31.1 9511
4 CERTIFICATION f10q0920ex31-2_inmed.htm EX-31.2 9527
5 CERTIFICATION f10q0920ex32-1_inmed.htm EX-32.1 2993
6 CERTIFICATION f10q0920ex32-2_inmed.htm EX-32.2 2965
7 GRAPHIC img_001.jpg GRAPHIC 13138
  Complete submission text file 0001213900-20-043142.txt   4068511

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE inm-20200930.xml EX-101.INS 588350
9 XBRL SCHEMA FILE inm-20200930.xsd EX-101.SCH 62782
10 XBRL CALCULATION FILE inm-20200930_cal.xml EX-101.CAL 22660
11 XBRL DEFINITION FILE inm-20200930_def.xml EX-101.DEF 184134
12 XBRL LABEL FILE inm-20200930_lab.xml EX-101.LAB 370976
13 XBRL PRESENTATION FILE inm-20200930_pre.xml EX-101.PRE 198367
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 201394051
SIC: 2834 Pharmaceutical Preparations